Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix<sup>®</sup>30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE<sup>™</sup>observational study - Concepedia

Concepedia

Publication | Open Access

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix<sup>®</sup>30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE<sup>™</sup>observational study

DOI Full Paper Access

46

Citations

21

References

2009

Year

Janusz Gumprecht, Marian Benroubi, Ryuzo Kawamori, J. Shában, Shreyas Shah, Robert J. Ligthelm, P. Valensi

International Journal of Clinical Practice

Abstract

Patients with type 2 diabetes inadequately controlled on basal insulins may improve their glycaemic control by intensification to BIAsp 30 therapy.

References

	Year	Citations

Page 1